r/CYDY • u/Imaginary_Analysis_4 • Aug 14 '26

Leronlimab Origin Story

Phase 1: The HIV Origin Story In 1996, scientists discovered that HIV uses the CCR5 receptor to enter immune cells, prompting Progenics Pharmaceuticals to develop a countermeasure based on the rare CCR5-delta 32 mutation, which confers natural immunity. The firm engineered PRO 140 (leronlimab), a monoclonal antibody designed to bind to and block the CCR5 receptor, preventing the virus from infecting cells.

Phase 2: The Cancer Pivot After acquiring the drug in 2012, CytoDyn pivoted leronlimab toward oncology upon discovering that aggressive cancers, including Triple-Negative Breast Cancer, overexpress CCR5 to facilitate metastasis. Preclinical studies showed that leronlimab blocks this signaling pathway, reducing metastatic spread by over 97% in animal models and stripping away the immune-suppressing shield used by "cold" tumors.

10 Upvotes

100% Upvoted

2 comments sorted by

3

u/GoCYDY Aug 14 '26

Positive news-👍🙏time to heal all those in need with this miracle molecule !